Production (Stage)
BioRestorative Therapies, Inc.
BRTX
$1.66
$0.063.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -226.37% | -49.91% | 72.91% | -81.20% | 3.50% |
| Total Depreciation and Amortization | 2.78% | 4.35% | 1.26% | 11.71% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 398.62% | 3.24% | -145.73% | 468.01% | -37.81% |
| Change in Net Operating Assets | -135.21% | -60.23% | 15.44% | 140.57% | -468.47% |
| Cash from Operations | -18.36% | -38.14% | 8.88% | 19.53% | -45.96% |
| Capital Expenditure | -193.55% | 78.80% | -65.72% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 55.56% | 55.25% | -66.92% | 161.05% | -33,197.30% |
| Cash from Investing | 54.44% | 63.60% | -68.49% | 160.33% | -5,711.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -100.00% | 8,958.97% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 133.57% | 78.79% | -4,551.56% | -34.74% | -- |
| Cash from Financing | 965.16% | -- | 100.00% | -100.17% | 8,947.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 172.31% | -23.44% | -169.65% | 301.61% | 117.15% |